CTAGE3P

Across TCGA pan-cancer cohorts, CTAGE3P RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of CTAGE3P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where CTAGE3P RNA is repressed in tumor relative to normal tissue. In most cancer types CTAGE3P is over-expressed in tumor, although a few such as THCA and LUAD show the opposite, repressed pattern.

THCA, KIRC, and COAD are the cancer types where CTAGE3P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CTAGE3P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	II,III,IV	−0.144	<.001	11	view →
KIRC	All	All	+0.082	<.001	8	view →
COAD	All	All	+0.097	.005	6	view →
UCEC	All	IV	+0.469	.024	4	view →
BRCA	All	All	+0.115	<.001	4	view →
LUAD	Female	All	−0.105	<.001	2	view →
PAAD	Female	All	+0.100	.019	2	view →
HNSC	Male	All	−0.027	.039	2	view →
READ	All	All	+0.206	.040	1	view →
KICH	All	II,III,IV	+0.118	.020	1	view →
LIHC	All	All	+0.046	.013	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

CTAGE3P–THCA

Open the THCA breakdown →